LIPOSOMALLY ENCAPSULATED HYBRID ADENOVIRUS-SEMLIKI FOREST VIRUS (SFV) VECTORS CARRYING RNAI CONSTRUCTS AND THERAPEUTIC GENES FOR USE AGAINST CANCER TARGETS AND OTHER DISEASES
    1.
    发明申请
    LIPOSOMALLY ENCAPSULATED HYBRID ADENOVIRUS-SEMLIKI FOREST VIRUS (SFV) VECTORS CARRYING RNAI CONSTRUCTS AND THERAPEUTIC GENES FOR USE AGAINST CANCER TARGETS AND OTHER DISEASES 审中-公开
    携带RNAI构建体和治疗癌基因用于癌症目标和其他疾病的感染性混合性ADENOVIRUS-SEMLIKI FOREST VIRUS(SFV)载体

    公开(公告)号:US20100008977A1

    公开(公告)日:2010-01-14

    申请号:US12439636

    申请日:2007-09-03

    IPC分类号: A61K9/127 C12N15/00 A61K35/76

    摘要: A hybrid adenovirus Semliki Forest Virus (SFV) vector includes 3′ and 5′ inverted terminal repeat (ITR) of adenovirus, the packaging signal of adenovirus, the structural genes encoding the adenovirus hexon and penton proteins, fiber and knob proteins and that may be deleted in the E4 region, E2 region or in the both the E2 and E4 regions. The adenovirus vector may not require a helper virus coinfection for propagation in producer cell lines. A hybrid vector includes a eukaryotic promoter controlling expression of the 42S genome of SFV comprising the nonstructural genes 1-4 or two point mutations thereof, and the therapeutic mRNA, in the cytoplasm. In use, the hybrid vector further comprises cDNA encoding for microRNA (miRNA) and hairpin loops of short interfering RNA (siRNA) or cDNA encoding for double-stranded RNA (dsRNA).

    摘要翻译: 杂合腺病毒塞立利森林病毒(SFV)载体包括腺病毒的3'和5'反向末端重复(ITR),腺病毒的包装信号,编码腺病毒六邻体和penton蛋白的结构基因,纤维和旋钮蛋白,并且可以是 在E4区域,E2区域或E2和E4区域都被删除。 腺病毒载体可能不需要辅助病毒共感染用于在生产细胞系中繁殖。 杂交载体包括控制包含非结构基因1-4或其两个点突变的SFV的42S基因组表达的真核启动子和细胞质中的治疗性mRNA。 在使用中,杂交载体还包含编码微小RNA(miRNA)的cDNA和短干扰RNA(siRNA)的发夹环或编码双链RNA(dsRNA)的cDNA。

    CANCER TREATMENTS
    2.
    发明申请
    CANCER TREATMENTS 审中-公开
    癌症治疗

    公开(公告)号:US20090053302A1

    公开(公告)日:2009-02-26

    申请号:US12281541

    申请日:2007-03-05

    摘要: The present invention relates to liposome comprising encapsulated oxaliplatin and methods for making encapsulated oxaliplatin. The invention also relates to liposomes comprising oxaliplatin and another anticancer drug. The liposomes of the invention are useful in cancer treatments.

    摘要翻译: 本发明涉及包含奥沙利铂的脂质体和用于制备包封的奥沙利铂的方法。 本发明还涉及包含奥沙利铂和另一种抗癌药物的脂质体。 本发明的脂质体可用于癌症治疗。